nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aerosolized Beractant in neonatal respiratory distress syndrome: A randomized fixed-dose parallel-arm phase II trial
|
Sood, Beena G. |
|
|
66 |
C |
p. |
artikel |
2 |
An expert panel delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil
|
Rahaghi, Franck F. |
|
|
66 |
C |
p. |
artikel |
3 |
Editorial Board
|
|
|
|
66 |
C |
p. |
artikel |
4 |
Efficacy and safety of inhaled nebulized sodium nitrite in asthmatic patients
|
Sriboonyong, Tidarat |
|
|
66 |
C |
p. |
artikel |
5 |
Evaluation of the combination of endothelin receptor antagonists (ERA) and phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension (PAH) in pathologic human pulmonary arteries in an ex-vivo organ bath model
|
Englert, L. |
|
|
66 |
C |
p. |
artikel |
6 |
Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19
|
S, Sugin Lal Jabaris |
|
|
66 |
C |
p. |
artikel |
7 |
TPMT and HLA-DQA1-HLA-DRB genetic profiling to guide the use of azathioprine in the treatment of interstitial lung disease: First experience
|
Taha, Nada |
|
|
66 |
C |
p. |
artikel |
8 |
Treprostinil palmitil, an inhaled long-acting pulmonary vasodilator, does not show tachyphylaxis with daily dosing in rats
|
Chapman, Richard W. |
|
|
66 |
C |
p. |
artikel |
9 |
Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: much caution is warranted
|
Mura, Marco |
|
|
66 |
C |
p. |
artikel |